These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22660961)

  • 21. Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma.
    Diete S; Treuheit T; Dietzmann K; Schmidt U; Wallesch CW
    J Neurooncol; 2001 May; 53(1):47-9. PubMed ID: 11678430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
    Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
    J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and relative survival of anaplastic astrocytomas.
    Smoll NR; Hamilton B
    Neuro Oncol; 2014 Oct; 16(10):1400-7. PubMed ID: 24723565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
    Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
    Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brain tumors in infants and children--factors affecting prognosis. (2) Location and prognosis of astrocytoma].
    Oi S; Raimondi AJ
    No Shinkei Geka; 1983 Oct; 11(10):1049-57. PubMed ID: 6646337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical prognostic factors in adults with astrocytoma: Historic cohort.
    Wegman-Ostrosky T; Reynoso-Noverón N; Mejía-Pérez SI; Sánchez-Correa TE; Alvarez-Gómez RM; Vidal-Millán S; Cacho-Díaz B; Sánchez-Corona J; Herrera-Montalvo LA; Corona-Vázquez T
    Clin Neurol Neurosurg; 2016 Jul; 146():116-22. PubMed ID: 27208871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary malignant brain tumor incidence and Medicaid enrollment.
    Sherwood PR; Stommel M; Murman DL; Given CW; Given BA
    Neurology; 2004 May; 62(10):1788-93. PubMed ID: 15159479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glioblastoma survival in the United States before and during the temozolomide era.
    Johnson DR; O'Neill BP
    J Neurooncol; 2012 Apr; 107(2):359-64. PubMed ID: 22045118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain tumours in the elderly.
    Twomey C
    Age Ageing; 1978 Aug; 7(3):138-45. PubMed ID: 212936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.
    Joo JD; Kim H; Kim YH; Han JH; Kim CY
    J Korean Med Sci; 2015 Nov; 30(11):1597-603. PubMed ID: 26539003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.
    Burger PC; Vogel FS; Green SB; Strike TA
    Cancer; 1985 Sep; 56(5):1106-11. PubMed ID: 2990664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boron neutron capture therapy. Clinical brain tumor studies.
    Nakagawa Y; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):105-15. PubMed ID: 9151228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary brain tumors].
    Cohen J; Cohen Y; Kuten A
    Harefuah; 1996 Nov; 131(10):387-90, 456. PubMed ID: 8981815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term risk of malignant astrocytic tumors after structural brain injury--a nationwide cohort study.
    Munch TN; Gørtz S; Wohlfahrt J; Melbye M
    Neuro Oncol; 2015 May; 17(5):718-24. PubMed ID: 25416827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG-PET as a prognostic factor in high-grade astrocytoma.
    De Witte O; Lefranc F; Levivier M; Salmon I; Brotchi J; Goldman S
    J Neurooncol; 2000 Sep; 49(2):157-63. PubMed ID: 11206011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).
    Urtasun RC; Cosmatos D; DelRowe J; Kinsella TJ; Lester S; Wasserman T; Fulton DS
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):207-14. PubMed ID: 8407393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology.
    Helseth A; Mørk SJ
    APMIS; 1989 Jun; 97(6):547-55. PubMed ID: 2736107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery.
    Wang YY; Yang GK; Li SY; Baol XF; Wu CY
    Chin Med Sci J; 2004 Jun; 19(2):105-10. PubMed ID: 15250245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.